Projects related to health services research

Institute of Medical Sociology, Health Services Research, and Rehabilitation Science

Integrated, cross-sectoral Psycho-oncology (isPO)

Scientific project leader of external evaluation: Prof. Dr. Holger Pfaff, Dr. Nadine Scholten, Dr. Antje Dresen

Operative project leader: Imke Jenniches

Project execution: Natalia Cecon, Sandra Salm

Duration: 10/2017 - 09/2021

Projektförderung: Innovation Committee (Innovationsausschuss) of the Federal Joint Committee (G-BA)

Project description:

Over 420,000 people in Germany contract cancer every year. Of these, about 20% to 30% suffer from comorbid mental disorders and about 50% from anxieties and depression at the time of diagnosis and during therapy. Although an integrated and cross-sectoral psycho-oncological care is nationally and internationally regarded as a standard, it is still not implemented in Germany.

Only 9% of 6,000 interviewed cancer patients stated that they received in-patient psycho-oncological care and 3% that they went to a cancer counselling center.

The aim of the project isPO is to develop, implement, and evaluate a psycho-oncological care programme. Therefore, structures, processes and results of care provision are described and transparently and comprehensibly documented. Quality assurance measures are conducted as well.

The specific patient-oriented goal is to reduce recurrent acute psychological stress reactions such as anxieties and depression of cancer patients within the first year after initial diagnosis. In the isPO programme, psycho-oncological care is given starting from the time of the cancer diagnosis and is provided cross-sectorally over a period of 12 months. This is done by coordinated, individualized psycho-oncological support and patient information in the conurbation of Cologne and in three rural regions in North Rhine-Westphalia. The provision of psychosocial and/or psychotherapeutic care for a cancer patient depending on his or her need is guaranteed by physician-led care networks.

As a cooperation partner in the project isPO, the IMVR conducts the independent evaluation of the care programme examining its effectiveness and quality.

The scientific monitoring is carried out as a prospective, process and outcome evaluation. Document analyses, qualitative and quantitative interviews with patients, care providers and other potential users of the isPO programme as well as analyses of health insurance data are carried out.


Evaluation of the Fitkids Program for a Healthy Growing up of Children of Parents Suffering from Addiction (EvaFit II)

Scientific project leader: Prof. Dr. Holger Pfaff, Jun.-Prof. Dr. Lena Ansmann

Operative project leader: Kira Hower

Cooperation partner: Information and aid in drug issues e. V. Wesel, Jörg Kons and Sandra Groß

Duration: 07/2017 bis 12/2018

Funding institution: Auridis GmbH

Project description:

Currently, about 50,000 children of drug-addicted parents are living in Germany. Repeatedly, the media reports tragic deaths and cases of neglect of infants and young children of drug addicts. To consider the situation of children of addicts, an opening and widening of the activities of drug-counseling centers is necessary. So far, only 10% of drug-counseling centers in Germany offer activities directed to children of drug-addicted parents or involve them in drug and addiction support. Accordingly, drug counseling is not prepared to care for children of addicts.

Implementing this topic into the existing structures and processes of drug and addiction support is a complex task. The Fitkids Program was developed by a drugs counseling center in Wesel with this in mind. Fitkids offers a supportive framework to continuously maintain dialog on the topic in drug counseling centers and to enable training, information and implementation processes.

The ultimate objective of Fitkids is to enable children with drug-dependent parents to grow up healthily and in an age-appropriate way. The program aims to achieve this by sustainably implementing children-oriented structures and processes in drug-counseling centers (click here to read more: http://www.fitkids-wesel.de/).

Following the results of a formative evaluation of the Fitkids Program, the implementation process was optimized, and the Institute of Medical Sociology, Health Services Research and Rehabilitation Science (IMVR) of the University of Cologne was commissioned with a further evaluation (2015 - 2017). This “Evaluation study of the Fitkids program for children orientation in drug counseling centers” (EvaFit) was conducted as a summative evaluation to investigate the implementation of the program in 15 drug counseling centers and 10 drug counseling centers, which piloted the program 4-5 years ago, from the perspective of management and employees (http://www.imvr.de/index.php?page=fitkids).

Cross-sectional qualitative study with semi-structured individual interviews with parents and children

As the Fitkids Program is a complex intervention, further evaluation studies are needed (EvaFit II) to comprehensively evaluate the program. In this second stage of evaluation, the quality of program provided and its effects will be evaluated from the perspective of the target group concerned - parents suffering from drug addiction and their children.

The evaluation has the primary characteristics of a summative evaluation; i.e. a comparison between postulated and achieved goal attainment within the Fitkids Program.

The assessment tools used in the study will be developed based on the results of EvaFit, previous experience of the evaluating researchers and the current state of research. 30 semi-structured individual interviews with parents addicted to drugs or their children are planned.


MamBo – People with Multimorbidity in Outpatient Care: Patient-Focused and Needs-Oriented Healthcare Management

Scientific project leader: Prof. Dr. Holger Pfaff, Dr. Ute Karbach

Operative project leader: Ibrahim Demirer

Projektmitarbeiter: Simone Richter

Cooperation partner:

Duration: 07/2017 - 06/2020

Funding institution: Innovation Committee (Innovationsausschuss) of the Federal Joint Committee (G-BA)

Project description:

Adequately and efficiently treating patients with complex multimorbid disease situations requires well-structured, informed and cross-indication treatment. Disease-specific healthcare structures cannot be provided for every disease. For this reason, a disease-spanning metastrategy will be pursued and the necessary structures established in the MamBo Project.

Public health and individual goals will be focused on in equal measure for this cross-indication collective healthcare. Framework conditions will be created to enable patient-relevant and comprehensive sector information to reach the physician administering treatment. The cross-practice delegation of near-patient and coordinative tasks thus relieves the burden on the physician. The structure required for this innovation in healthcare is composed of demand management on the part of the payer, of care management on the part of the physician network involved and of continuous improvement processes, which are discussed in regular meetings with those involved in the process. The aim of the project is, firstly, to identify those factors conducive and restrictive to the implementation of this innovation in healthcare in an accompanying formative evaluation. Secondly, structure, process and result quality will be examined from multiple perspectives in a summative evaluation. This examines whether a change in healthcare quality and healthcare efficiency is effected by the MamBo structure in the Leverkusen region (Germany) and how cooperation in the various disciplines is developing.

Within the framework of the formative evaluation, annual focus groups and individual interviews with those involved in the process will be conducted, recorded, transcribed, assessed with regard to content analysis and then presented in results workshops.

Various primary and secondary data sources will be used in the summative evaluation. Postal surveys of patients, physicians and practice employees conducted at two points in time will enable a pre-post comparison. Health insuerers' administrative data (claims data) of the MamBo population will be compared with those of a comparative population in various capacities in a semi-experimental design. The comparative population will be formed according to the propensity score matching method. In addition, secondary data from documents of the physician network will be analyzed in the summative evaluation.


APVEL - Evaluation of specialized outpatient palliative care

Scientific project leader: Prof. Dr. Holger Pfaff, Dr. Nadine Scholten

Project execution: Anna Arntz, Sophie Peter

Duration: 06/2017 - 05/2019

Funding institution: Innovation Committee (Innovationsausschuss) of the Federal Joint Committee (G-BA)

Project description:

German outpatient palliative care is divided into general outpatient palliative care (AAPV) and specialized outpatient palliative care (SAPV). Both forms enable ill and dying persons to spend their remaining time at home so that they can die in a familiar environment. The aim of outpatient palliative care is to provide an increase in quality of life and support patients and their relatives to preserve their self-determination. Additional goals are the alleviation of symptoms such as the reduction of pain. SAPV is based on high standards in providing care and requires an interdisciplinary approach. Therefore, physicians exclusively prescribe SAPV to patients with a complex symptomatology.

The chairs of palliative medicine of Aachen, Bonn, and Cologne aim to evaluate SAPV in the Province of North Rhine. The project contrasts SAPV with AAPV. There are three main research goals. The first part deals with the analysis of administrative health insurance data. So it is focused on patient characteristics and health care tracks as well as health care differences between patients that receive AAPV or SAPV. The second section examines SAPV and AAPV from the patient’s point of view as well as from the perspective of their relatives and palliative care providers.

The third part of the project is located in the Institute of Medical Sociology, Health Services Research, and Rehabilitation Science (IMVR). The institute investigates distinctive features of SAPV and AAPV according to the opinion of general practitioner and oncologists in the outpatient sector. The objective is to analyze decisions of both disciplines for prescribing SAPV instead of AAPV and to define the term “complex symptomatology.” The design of the study is based on mixed methods. The initial stage of the project process includes qualitative expert interviews and focus groups. Afterwards, a quantitative questionnaire will be developed on the basis of the qualitative research results.


AdAM (Application for Digitally Supported Pharmacotherapy Management)

Scientific project leader: Prof. Dr. Holger Pfaff, Dr. Ute karbach

Project execution: Sara Söling

Cooperation partner:

Duration: 10/2016 - 09/2019

Funding institution: Innovation Committee (Innovationsausschuss) of the Federal Joint Committee (G-BA)

Project duration:

Many elderly people suffer from multimorbidity and require several drugs simultaneously. The medical treatment of these patients brings with it an increased risk of drug interaction, side effects and medication errors. AdAM contains specially developed software, which offers physicians digital support to improve the quality, safety and coordination of pharmacotherapy and healthcare management. The software has various functions, such as:

  1. Extracting treatment-relevant patient information from health insurance carrier routine data in real time with the patient’s informed consent
  2. Conducting electronically supported drug safety tests and printing the required standard German drug charts in various languages for patients
  3. Sending automatic risk warnings in the event of medication errors
  4. Automatic notifications when outpatients are admitted for inpatient treatment and coordinating drug administration with the hospital

IMVR will conduct the formative evaluation of the new AdAM form of healthcare, thus presenting which factors conducive and restrictive to implementation may be observed in the application of this digitally supported pharmacotherapy management. Participating general practitioners in the control group and intervention group will be asked questions regarding those factors conducive and restrictive to implementation (user-friendliness of the software, obstacles) in guided telephone interviews and focus groups will be organized with those who have been using the application for a while and those who have started using it recently. Based on the results of this qualitative data collection, a postal survey (quantitative) will be developed and employed in participating practices to record factors relevant to physicians and practices. Qualitative evaluation will either be content analytical or qualitative descriptive, depending on the issue being addressed. The survey will be descriptive.


Multidimensional analysis of causes for the low prevalence of ambulatoy peritoneal dialysis in Germany (MAU-PD)

Scientific project leader: Dr. Nadine Scholten

Operative project leader: Tim Ohnhäuser

Project execution: Isabell Schellartz

Scientific cooperation partner: Dr. Ute Karbach, Dr. Gero von Gersdorff, Dr. Katherine Rascher (Department II of Internal Medicine - QiN group, University Hospital of Cologne), Prof. Dr. Martin Hellmich, Christina Samel (Institute of Medical Statistics and Computational Biology, University of Cologne (UoC)), Prof. Dr. Thomas Mettang (Center for Kidney Disease and Hypertension, Wiesbaden) Prof. Dr. Stephanie Stock, Dusan Simic, Kristina Lorrek (Institute for Health Economics and Clinical Epidemiology, Cologne University Hospital, UoC), DAK Gesundheit, Siemens Betriebskrankenkasse (SBK)

Duration: 05/2017 - 04/2020

Funding institution: Innovation Committee (Innovationsausschuss) of the Federal Joint Committee (G-BA)

Project description:

From a medical perspective, peritoneal dialysis (PD) and hemodialysis (HD) are equivalent treatment options for patients with chronic kidney disease (CKD). Findings show that PD rates vary considerably worldwide (e.g., Hong Kong 79.4%, Sweden 23.8%, Germany 5.4%, and Luxembourg 0.7%). The objective of the project is to identify causal factors for the low PD rate in Germany. The effect of these factors can be the promotion or inhibition of PD from different perspectives of patients, physicians, nurses, and sickness funds. In this cross sectional study, our focus is on the health care situation of dialysis patients at a local level as well as the different costs and cost categories (HD vs. PD). Furthermore, we analyze the identification and weights of factors of patients, physicians, and nurses that are relevant for modality choice. The study is funded by the Innovation Committee of the Federal Joint Committee. The health care situation is represented by secondary data analysis. Data resources consist of panel medical care accounting data produced by the Central Research Institute of Ambulatory Health Care of the National Association of Statutory Health Insurance Physicians; claims data from two cooperating statutory health insurance companies; and quality assurance data from KfH (QiN – Quality in Nephrology), an ambulatory dialysis provider in Germany. Using a mixed methods design, we conduct qualitative individual interviews with patients and focus groups with nephrologists and nurses as well as a quantitative survey using a standardized questionnaire. Different questionnaires are targeted at health care professionals (physicians, dialysis nursing managers, and dialysis nursing staff) and patients. This data enables the identification of causal factors for the uptake of PD as well as its distribution and relevance.

We expect a representative quantitative analysis of factors influencing the treatment choice for or against PD. Finally, an action plan including practical solutions is derived from the results of this analysis. These results can reveal approaches at different levels of health care delivery, including at the organizational level with internal and external organizational structures and processes and at the individual level of physicians and patients. In addition, the results open up a major discussion for all players in the health care sector (e.g., dialysis providers, funders, etc.).


Value Stream Mapping in Breast Cancer Centers – a solution approach to improve the discharge process „VaMB“

Scientific project leader: Dr. Ute Karbach

Operative project leader: Marina Nowak

Project execution: Kerstin Dittmer

Scientific collaboration partners: Prof. Dr. Martin Hellmich, Christina Samel (Institute of Medical Statistics and Computational Biology, University of Cologne), Hilde Schulte (Frauenselbsthilfe nach Krebs Bundesverband e.V.), Prof. Dr. Rita Schmutzler (Center for Hereditary Breast and Ovarian Cancer, University Hospital Cologne

Duration: 05/2017 - 04/2020

Funding institution: Innovationsausschuss beim Gemeinsamen Bundesausschuss (G-BA)

Project description:

The discharge of patients from breast cancer centers has to be prepared adequately to guarantee a successful transition to general practitioners. However, the discharge process is often affected by unnecessary waiting times. Patients evaluate the process rather negatively. In addition, the process is challenging for the involved personnel.

Value Stream Mapping aims to improve the discharge process. The methods visualizes complex work flows and thereby intents to create a more efficient and value-adding process. For the patient, value-adding could imply, for instance, a follow-up treatment within the breast cancer center.

Research question: The project at hand considers the question whether the discharge process in breast cancer centers can be improved by using Value Stream Mapping. The project aims to evaluate the method of Value Stream Mapping when applied to the discharge process of breast cancer centers.

Four certified breast cancer centers in North Rhine-Westphalia form project teams out of employed representatives of all involved occupational groups (e.g. administration, nursing, medical staff). The discharge is visualized together with a trained facilitator. The project team analyzes the current state value stream map together with a patient representative. The time needed for the discharge is determined, process steps are analyzed and causes of missing value for the patient are identified. Based on this information, the project team improves the discharge process and creates a renewed future state value stream map. Finally, the new process will be implemented.

The intervention is evaluated based on a before-after-follow-up study design. The discharge process is measured in the four participating breast cancer centers before the intervention, directly afterwards and six months later. The evaluation is carried out through time measurement and questionnaires for patients and employees. These data are analyzed by descriptive and inferential statistical methods.


Cologne Research and Development Network - CoRe-Net

 

The project CoRe-Net started in February 2017 with the aim of developing a Cologne Research and Development network. As one of a few regions Cologne was chosen by the Federal Ministry of Education and Research for this unique promotion of structural development. CoRe-Net was established to be a long-term and sustainable network making Cologne into a model region for the improvement of health and social care in Germany. The network will be funded by the BMBF for the next three years.

The network is intended to bring together the fields of health services research and practice in Cologne. This will be accomplished by creating structures that promote an exchange between scientists and practitioners.

Furthermore, the created structures will enable innovative health care research projects. For this purpose, a unique CoRe-Net database will be established that contains claims data, social statistics, and field data. You will find more information about CoRe-Net and the database here.

CoRe-Net currently includes three subprojects: LYOL-C, MenDis-CHD, and OrgValue. These projects, which examine health care across different care organizations for specific patient groups in Cologne, also aim to identify organizational characteristics hindering or facilitating the implementation of patient-centered care.

The development of the network involves three faculties of the University of Cologne: the faculties of Human Sciences; Medicine; and Management, Economics, and Social Sciences. This interdisciplinary cooperation enables the integration of different perspectives and methods.


OrgValue – Characteristics of Value-Based Health and Social Care from Organizations‘ Perspective

Scientific project leader: Dr. Anna Choi

Operative project leader: Kira Hower

Scientific collaboration partners: Prof. Dr. Stephanie Stock, Vera Vennedey (Institut für Gesundheitsökonomie und Klinische Epidemiologie), Prof. Dr. Ludwig Kuntz, Hendrik Hillen (Seminar für ABWL und Management im Gesundheitswesen)

Duration: 02/2017 - 01/2020

Funding institution: Federal Ministry of Education and Research

Project description:

Health care systems are under pressure to organize care around patients’ needs with strained resources. Several studies reveal that care is primarily supply-driven rather than patient-centered. Therefore, value-based health and social care aims to redesign care delivery around patient-centeredness whilst taken the resources spent into consideration.

OrgValue is one of three scientific projects of the Cologne Care Research and Development Network (CoRe-Net).

The organizations in Cologne caring for vulnerable patient groups studied in the subprojects LYOL-C and MenDis-CHD are examined in OrgValue using a mixed methods approach.

The implementation status of patient-centeredness and resource orientation as well as its facilitators and barriers are assessed through face-to-face interviews with decision makers from HSCOs in Cologne. Additionally, patients’ understanding of patient-centeredness and their preferences and needs are surveyed conducting focus groups and face-to-face interviews. This opens up a comparison of organizations’ and patients’ perspectives on patient-centeredness.

The qualitative results provide the basis for a quantitative survey with decision makers from all HSCOs in Cologne. All examinations include questions on patient-centeredness, resource orientation and determinants of implementation like organizational climate and culture. The development of a diagnostic and feedback-tool for self-evaluation out of the aforementioned survey is taken into consideration.


BGM-innovativ: Workplace, cross-provider healthcare management of company health insurance funds

Scientific project leader: Prof. Dr. Holger Pfaff

Operative project leader: Dr. Anna Choi

Project execution: Lara Lindert, Dr. Birthe Lehmann

Co-operation partners: BKK Federal Association, 15 company health insurances and 22 companies, Institute of Medical Statistics and Computational Biology (IMSIE), Insurance Agencies of the German Statutory Pension Insurance, German Society for Medical Rehabilitation (DEGEMED)

Duration: 04/2017 - 03/2021

Funding institution: Innovation Committee (Innovationsausschuss) of the Federal Joint Committee (G-BA)

Project description:

BGM-innovativ for employees with musculoskeletal disorders is a response to the specific needs for healthcare in companies. The objective of the program is to offer sick or vulnerable employees targeted support tailored to their individual needs during recovery and the provision of healthcare. This will be ensured by cross-carrier and cross-sector coordinated healthcare. The various social security carriers are faced with similar needs for action in preventive, curative and rehabilitative treatment, care and support. However, their measures have been taking place in a largely disjointed and uncoordinated manner so far. For this reason, BGM-innovativ intends to establish close cooperation and coordination between the relevant health insurance carriers, pension providers and companies. Thus BGM-innovativ is an approach to combat insufficient cross-sector healthcare cooperation for employees with musculoskeletal disorders.

The program aims to avoid disease and chronification, reduce disease duration and days of absence and to permanently maintain capacity for work. Companies and employees will be supported in the field of corporate healthcare management (BGM) by healthcare management oriented to each individual workplace situation. A central innovation of BGM-innovativ is the case manager of the company health insurance funds, who is the personal contact for policy holders, organizes specific and appropriate healthcare and coordinates the interfaces between the various parties. The case manager leads the employees through the healthcare process and involves them in all planning and decision-making processes. BGM-innovativ has a multimodal structure and intends to establish workplace-relevant, individualized and cross-sector healthcare measures. Depending on the stage of the disease and the impact on the employee, these measures may be early intervention, rehabilitation or reintegration. We refer to BGM-innovativ as a metaconcept; instead of creating additional structures and services, it strengthens cross-system thinking and the awareness of the various parties. Key factors like the case manager, who takes over a guiding role for policy holders in the healthcare process, will be implemented once and can then be applied in further contexts, indications, sectors, regions and health insurance funds. Whereas the supported project primarily focusses on musculoskeletal diseases, should the project be successful, the concept could be applied to the healthcare processes of different, high-prevalence diseases. IMVR will coordinate the evaluation of the BGM-innovativ program. The design of the study employs a mixed-method approach and consists of both an accompanying, process-oriented (formative) and a result-oriented (summative) evaluation

Summative evaluation using a randomized trial The summative evaluation aims to check the effectiveness of the program using a randomized controlled trial (RCT). The participants are randomly divided into two treatment groups before the program commences for this purpose. All participants receive a standardized questionnaire at the beginning and in the end of the program. Furthermore, additional key figures, like information regarding incapacity for work, are evaluated. Using the pre-post comparison and the comparison of the two groups in each module, robust conclusions can be drawn on the effectiveness of the program. Additional qualitative interviews with some participants supplement the summative evaluation.

Formative evaluation using qualitative methods Formative evaluation with qualitative implementation research meant to identify those factors conducive and restrictive to implementation of the program will take place alongside it. Relevant parties (like case managers and company physicians) will be asked about their subjective experiences of implementation of the program in focus groups and expert interviews. These surveys will take place at several points throughout the project to obtain as comprehensive a picture as possible.

The results of the evaluation will make an important contribution to evidence-based corporate health and healthcare management. They will promote cross-carrier and cross-sector cooperation between the various healthcare parties and therefore improve the targeted and individual support of sick employees during recovery and in the provision of healthcare.


Occupational rehabilitation after breast cancer - differences between hospitals regarding frequency and length (B-Rehab)

Project leader and execution: Prof. Dr. Holger Pfaff, Dr. Nadine Scholten

Duration: 02/2014 - 2020

Funding institution: The study is funded with IMVR’s own resources

Project description:

At the time of the first breast cancer diagnosis, the majority of affected women and men are still at an employable age (median: 60 years). Work is associated with higher quality of life, more self-esteem and a sense of normality. Therefore, returning back to work must be a declared aim for all patients who are employed prior to diagnosis. Studies have shown that oncologic patients often have problems in the work context. The probability of returning back to work is related to many different factors, for example age at the time of diagnosis, the severity of the disease and the type of treatment. So far, not much is known about the variation between hospitals in respect to the percentage of patients returning back to work and the length of sick leave. The aim of the project is to analyze possible variations between hospitals and assess the extent to which such differences can be explained by the characteristics of particular hospitals. This project is based on cooperation between the IMVR and the AOK Rheinland/Hamburg.

Given patients’ agreement to link their health insurance data with the data from the patient survey at the breast centers (“Routine survey”) these data basis are being linked und analyzed with reference to occupational rehabilitation after two and after five years.


The acute care hospital and its outpatient and inpatient medical services: A player in both sectors?

Scientific project leader: Prof. Dr. Holger Pfaff, Dr. Ute Karbach, Dr. Nadine Scholten

Project execution: Anna Arntz

Laufzeit: 01/2017 - 12/2017

Funding institution: Zentralinstitut für die Kassenärztliche Versorgung in Deutschland (Zi)

Project description:

 


Evaluation study of the Fitkids program for children-orientation in drug-counseling centers (EvaFit)

Project leader: Prof. Dr. Holger Pfaff, Jun.-Prof. Dr. Lena Ansmann

Project execution: Kira Hower

Operative project leader: Jörg Kons und Sandra Groß, Information und Hilfe in Drogenfragen e.V. Wesel

Duration: 06/2015 - 12/2017

Funding institution: Auridis GmbH

Project description:

 


Promoting the health literacy of managers – An evidence-based training program (HeLEvi)

Project leader: Prof. Dr. Holger Pfaff

Project execution: Dr. Timo-Kolja Pförtner, Silja Fiedler

Co-operation partners: Deutsche Sporthochschule Köln, Institut für Bewegungstherapie und bewegungsorientierte Prävention und Rehabilitation (Univ.-Prof. Dr. Ingo Froböse) Institut für Gesundheitsökonomie und Klinische Epidemiologie (IGKE) (Univ.-Prof. Dr. med. Stephanie Stock)

Duration: 02/2015 - 01/2018

Funding institution: Federal Ministry of Education and Research

Project description:

 


Rehabilitative health care for geriatric patients in Baden-Württemberg

Scientific project leader: Dr. Ingrid Schubert, Prof. Dr. Holger Pfaff

Operative project leader: IMVR: Dr. Ute Karbach

Project execution IMVR: Melanie Zirves

Co-operation partners: Prof. Dr. Wilhelm Niebling, Leiter des Lehrbereichs Allgemeinmedizin, Universitätsklinikum Freiburg AOK Baden-Württemberg

Duration: 09/2017 - 07/2018

Funding institution: Ministerium für Arbeit und Sozialordnung, Familie, Frauen und Senioren Baden-Württemberg

Project description:

 


NWOB - Organizational behaviour in health care institutions in Germany - theoretical approaches, methods and empirical results

Project leader: PD Dr. Mirjam Körner, Dr. Christoph Kowalski

Contact: Dr. Nadine Scholten

Co-operation partners: Arbeitsgruppe Versorgungsforschung der Deutschen Gesellschaft für Medizinische Soziologie (DGMS)

Duration: 06/2014 - 07/2017

Funding institution:

Project description: